Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (13233)	1/12/1998 12:08:00 PM
From: Andrew H	Respond to of 32384

>>Monday January 12, 10:54 am Eastern Time Company Press Release ADVISORY/BIOCOM/"State of the Industry, Part II" and "How Modernized Is FDA Now?" --(BUSINESS WIRE)-- WHAT: BIOCOM/San Diego's meeting, featuring "State of the Industry, Part II" (David Robinson, chairman, president and CEO, Ligand Pharmaceuticals Inc. [Nasdaq:LGND - news], and 1998 BIOCOM president) and a panel discussion on "How Modernized Is FDA Now?" The panelists are Tom Scarlett, Esq., Hyman Phelps & McNamara -- biotech; Mark Heller, Esq., Hale and Door -- devices; Sally Grigoriev, VP, quality and regulatory, Alaris Medical Systems; and Karen K. Church, RAC, VP, regulatory affairs, ABA. WHEN: Thursday, Jan. 15, 7:30 a.m. to 9:15 a.m. WHERE: Sheraton Grande Torrey Pines 10950 N. Torrey Pines Road, La Jolla WHY: Reporters will gain firsthand knowledge about the new medical legislation with legal and regulatory experts from biotechnology and medical-device perspectives. If you wish direct interviews with speakers, we will do our best to accommodate your request. MEDIA Members of the media will be comped with reservation by PASS: calling Marcelle Vogel, BIOCOM, at 619/455-0300. For more BIOCOM information, please see www.biocom.org<<